Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion type Assertion NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_head.
- NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_provenance.
- NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion evidence source_evidence_literature NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_provenance.
- NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion SIO_000772 20453058 NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_provenance.
- NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion wasDerivedFrom befree-2016 NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_provenance.
- NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion wasGeneratedBy ECO_0000203 NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_provenance.